October 9, 2008 — Stool DNA testing is a new approach to screening for colorectal cancer, but it is an evolving technology. A study has found that the first-generation stool DNA test (SDT-1) is not ...

An investigational multitarget stool DNA test for screening colorectal cancer detects significantly more cancers than the currently available fecal immunochemical test (FIT), researchers report. But ...

The FDA approved Exact Sciences’ Cologuard Plus multitarget stool DNA test to screen adults aged 45 years or older at average risk for colorectal cancer, according to a company press release. Compared ...

Colon CT scans might be able to prevent more colon cancers than stool DNA testing Two CT screening approaches outperformed stool DNA testing in computer models CT screening also was more ...

Annual fecal immunochemical test-based surveillance could be as effective as colonoscopies in reducing long-term colorectal cancer incidence and mortality, according to a recent study published in ...

CT colonography reduced the incidence of colorectal cancer by up to 75% versus no screening, while stool DNA testing reduced the incidence by 59%. Stool testing was cost-effective relative to no ...

This randomized trial showed that a personalized message about colorectal cancer risk to patients and providers had no effect on screening uptake. However, stool testing rates were higher with the ...

Have you ever thought, "I'm too young to get colon cancer"? The truth is that colorectal cancer (CRC) is affecting more younger adults than ever before. Despite this alarming trend, many people remain ...